Findings

What do systematic reviews say?

4 questions · 5 findings · 2 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 40%Low 1 · 20%Moderate 2 · 40%High 0 · 0%

Infliximab · people with chronic plaque psoriasis

Any systemic treatment probably leads to higher infliximab compared with placebo (moderate certainty).

2 findings from 1 review

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis 2020 · Cochrane Headline outcomes only
RR 29.52 [19.94, 43.7]
5 studies · 1651 participants
Moderate
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis 2020 · Cochrane Headline outcomes only
RR 1.11 [0.59, 2.07]
6 studies · 1678 participants
Moderate

Infliximab (1 RCT; 11 participants) · surgically induced remission in Crohn's disease

It is very uncertain whether the intervention changes infliximab (1 RCT; 11 participants) (very low certainty).

1 finding from 1 review

Infliximab (2 RCTs; 21 participants) · surgically induced remission in Crohn's disease

The intervention showed no clear difference in infliximab (2 RCTs; 21 participants) (low certainty).

1 finding from 1 review

Infliximab (2 RCTs; 21 participants) · surgically induced remission in Crohn's disease

It is very uncertain whether the intervention changes infliximab (2 RCTs; 21 participants) (very low certainty).

1 finding from 1 review